[1,3,10] to further investigate the proposed dual action of ibutilide. Our laboratory has sought to examine the effects of sodium channel blockade and calcium channel blockade on the ...

Ibutilide is the only Food and Drug Administration-approved intravenous drug for the rapid termination of atrial fibrillation and flutter. Its mechanism of action is undecided. The drug has been ...